Massaccesi, Mariangela
 Distribuzione geografica
Continente #
EU - Europa 3.601
NA - Nord America 3.403
AS - Asia 2.392
SA - Sud America 484
AF - Africa 81
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.969
Nazione #
US - Stati Uniti d'America 3.287
DE - Germania 1.668
SG - Singapore 1.141
CN - Cina 677
SE - Svezia 586
BR - Brasile 399
UA - Ucraina 302
IT - Italia 211
FR - Francia 205
GB - Regno Unito 173
IN - India 136
FI - Finlandia 115
IE - Irlanda 114
VN - Vietnam 103
ID - Indonesia 82
CA - Canada 78
RU - Federazione Russa 53
TR - Turchia 49
AR - Argentina 41
PL - Polonia 38
JP - Giappone 34
HK - Hong Kong 32
BD - Bangladesh 29
MX - Messico 25
NL - Olanda 24
ES - Italia 23
IQ - Iraq 23
BE - Belgio 19
CI - Costa d'Avorio 19
ZA - Sudafrica 17
CZ - Repubblica Ceca 14
EC - Ecuador 14
IR - Iran 13
KR - Corea 12
LT - Lituania 12
MA - Marocco 12
EG - Egitto 11
AT - Austria 10
UZ - Uzbekistan 9
CO - Colombia 8
AU - Australia 7
JO - Giordania 7
TN - Tunisia 6
VE - Venezuela 6
CH - Svizzera 5
CL - Cile 5
AM - Armenia 4
AZ - Azerbaigian 4
DZ - Algeria 4
IL - Israele 4
KE - Kenya 4
PK - Pakistan 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BO - Bolivia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
MY - Malesia 3
PE - Perù 3
PH - Filippine 3
UY - Uruguay 3
BG - Bulgaria 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
NO - Norvegia 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
AG - Antigua e Barbuda 1
AO - Angola 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
HU - Ungheria 1
IS - Islanda 1
MK - Macedonia 1
MW - Malawi 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 9.963
Città #
Chandler 572
Singapore 565
Ashburn 311
Jacksonville 158
Beijing 150
San Mateo 131
The Dalles 126
Dublin 112
Nanjing 107
New York 107
Los Angeles 98
Munich 89
Dearborn 88
Wilmington 80
Nürnberg 76
Jakarta 73
Boston 63
Hefei 63
Fairfield 55
Woodbridge 55
Houston 53
Bremen 52
Ann Arbor 48
Frankfurt am Main 46
Milan 45
Lawrence 44
Marseille 44
Seattle 43
São Paulo 43
Helsinki 41
Chicago 38
Ho Chi Minh City 37
Moscow 37
Cattolica 35
Dallas 35
Izmir 35
Nanchang 34
Hanoi 33
Hong Kong 30
Hyderabad 29
Toronto 28
Redmond 27
Buffalo 24
Redwood City 24
Warsaw 23
Norwalk 22
Princeton 22
Rome 22
North York 21
University Park 20
Abidjan 19
Brussels 19
Fremont 17
Kent 17
Shenyang 17
Tokyo 17
Turku 17
Lancaster 16
London 16
Santa Clara 16
Zhengzhou 16
Düsseldorf 15
Leawood 14
Stockholm 14
Augusta 13
Cambridge 13
Kunming 13
Atlanta 12
Boardman 12
Jiaxing 12
Seoul 12
Denver 11
Montreal 11
Nuremberg 11
Portsmouth 11
Tianjin 11
Wroclaw 11
Auburn Hills 10
Changsha 10
Guangzhou 10
Hangzhou 10
Mountain View 10
North Bergen 10
Poplar 10
Rio de Janeiro 10
Brasília 9
Hebei 9
Johannesburg 9
Lauterbourg 9
San Francisco 9
Amsterdam 8
Chennai 8
Falls Church 8
Goiânia 8
Paris 8
Roubaix 8
Washington 8
Amman 7
Andover 7
Berlin 7
Totale 4.699
Nome #
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 286
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 210
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 208
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 200
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 193
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 191
 ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose. 180
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 179
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 176
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 169
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 169
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 168
Experimental evaluation of the impact of low tesla transverse magnetic field on dose distribution in presence of tissue interfaces 167
 ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose 166
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 165
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 165
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 163
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 159
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 157
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 156
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 156
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 154
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 153
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 147
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 147
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 147
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 146
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 145
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 145
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 144
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 143
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 141
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 139
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 137
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 136
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 135
Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? 134
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 134
The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy. 134
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 129
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 129
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 128
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 127
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 124
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 119
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 117
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 116
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 111
A new standardized data collection system for brain stereotactic external radiotherapy: The PRE.M.I.S.E project 109
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 107
Hybrid Tri-Co-60 MRI radiotherapy for locally advanced rectal cancer: An in silico evaluation 105
Can automation in radiotherapy reduce costs? 103
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 102
A new frontier of image guidance: Organs at risk avoidance with MRI-guided respiratory-gated intensity modulated radiotherapy: Technical note and report of a case 101
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 99
Role of Peripheral Blood Markers for Detecting Response and Predicting Prognosis in Patients with Non-small-cell Lung Cancer Undergoing Neoadjuvant Therapy and Surgery 96
Predicting tumour motion during the whole radiotherapy treatment: a systematic approach for thoracic and abdominal lesions based on real time MR 96
Masaoka-koga and tnm staging system in thymic epithelial tumors: Prognostic comparison and the role of the number of involved structures 96
Ventricular tachycardia ablation through radiation therapy (VT-ART) consortium: Concept description of an observational multicentric trial via matched pair analysis 90
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics 89
Osteoradionecrosis incidence in pre‐radiation teeth extractions: A prospective study 86
The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: Low-dose fractionated radiotherapy with concurrent chemotherapy 86
REPeated mAgnetic resonance Image-guided stereotactic body Radiotherapy (MRIg-reSBRT) for oligometastatic patients: REPAIR, a mono-institutional retrospective study 84
Efficacy of an eye movement desensitization and reprocessing (EMDR) intervention for a head and neck cancer patient with intolerable anxiety undergoing radiotherapy 84
Authors' reply “Osteoradionecrosis incidence in preradiation teeth extractions: A prospective study” 82
Role of radiation oncology in modern multidisciplinary cancer treatment 82
Successful Treatment of Tumor-Induced Osteomalacia by Multidisciplinary Therapy with Radiation to Intracranial Fibromyxoid Tumor 82
Late tonsil metastases from renal cell cancer: a case report. 79
The Multidimensional Assessment for Pediatric Patients in Radiotherapy (M.A.P.-RT) Tool for Customized Treatment Preparation: RADAR Project 79
A predictive nomogram for trismus after radiotherapy for head and neck cancer 78
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 78
Unconventional radiotherapy to enhance immunotherapy efficacy in bulky tumors: a case report 77
Role of 18F-FDG PET/CT in Head and Neck Squamous Cell Carcinoma: Current Evidence and Innovative Applications 69
Sodium-hyaluronate mouthwash on radiotherapy-induced xerostomia: a randomised clinical trial 66
Magnetic resonance-guided stereotactic body radiation therapy (MRgSBRT) for oligometastatic patients: a single-center experience 65
Spatially fractionated radiotherapy (SFRT) targeting the hypoxic tumor segment for the intentional induction of non-targeted effects: An in silico study to exploit a new treatment paradigm 63
Interventional Radiotherapy (Brachytherapy) for Nasal Vestibule: Novel Strategies to Prevent Side Effects 62
Simultaneous integrated boost intensity-modulated radiotherapy for treatment of bone metastases: analysis of a breast cancer cohort 55
Quality control strategies for head and neck brachytherapy (interventional radiotherapy) 29
Early post-operative NI-RADS predicts recurrence and survival in high-risk oral cavity squamous cell carcinoma undergoing adjuvant radiotherapy 19
Gender role in radiotherapy: psychosocial differences between males and females during cancer care: Single-centre report on adult and paediatric oncological patients 1
Totale 10.043
Categoria #
all - tutte 37.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.980


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021328 0 0 0 0 0 28 72 18 74 28 86 22
2021/2022690 57 57 16 51 60 27 14 94 32 45 108 129
2022/20231.558 221 219 108 254 84 182 78 136 160 34 59 23
2023/2024664 23 167 22 47 20 105 34 57 3 16 108 62
2024/20251.677 31 43 113 51 195 44 30 89 259 224 345 253
2025/20262.155 545 135 205 488 718 64 0 0 0 0 0 0
Totale 10.043